Clinical Trial: ALLIANCE EAY191-A6

ALLIANCE EAY191-A6

Status: Open

FOLFOX in Combination with Binimetinib as 2nd Line Therapy for Patients with Advanced Biliary Tract Cancers with MAPK Pathway Alterations: A ComboMATCH Treatment Trial

(See required screening study ECOG-ACRIN EAY191)